Lo-Man R, Langeveld J P, Dériaud E, Jehanno M, Rojas M, Clément J M, Meloen R H, Hofnung M, Leclerc C
Unité de Biologie des Régulations Immunitaires, Institut Pasteur, Paris, France.
Infect Immun. 2000 Jun;68(6):3079-89. doi: 10.1128/IAI.68.6.3079-3089.2000.
We analyzed the CD4 T-cell immunodominance of the response to a model antigen (Ag), MalE, when delivered by an attenuated strain of Salmonella enterica serovar Typhimurium (SL3261pMalE). Compared to purified MalE Ag administered with adjuvant, the mapping of the peptide-specific proliferative responses showed qualitative differences when we used the Salmonella vehicle. We observed the disappearance of one out of eight MalE peptides' T-cell reactivity upon SL3261pMalE immunization, but this phenomenon was probably due to a low level of T-cell priming, since it could be overcome by further immunization. The most striking effect of SL3261*pMalE administration was the activation and stimulation of new MalE peptide-specific T-cell responses that were silent after administration of purified Ag with adjuvant. Ag presentation assays performed with MalE-specific T-cell hybridomas showed that infection of Ag-presenting cells by this intracellular attenuated bacterium did not affect the processing and presentation of the different MalE peptides by major histocompatibility complex (MHC) class II molecules and therefore did not account for immunodominance modulation. Thus, immunodominance of the T-cell response to microorganisms is governed not only by the frequency of the available T-cell repertoire or the processing steps in Ag-presenting cells that lead to MHC presentation but also by other parameters probably related to the infectious process and to the bacterial products. Our results indicate that, upon infection by a microorganism, the specificity of the T-cell response induced against its Ags can be much more effective than with purified Ags and that it cannot completely be mimicked by purified Ags administered with adjuvant.
我们分析了减毒鼠伤寒沙门氏菌(SL3261pMalE)递送模型抗原(Ag)MalE时,对其产生的CD4 T细胞免疫显性反应。与佐剂联合使用的纯化MalE抗原相比,当我们使用沙门氏菌载体时,肽特异性增殖反应的图谱显示出质的差异。我们观察到,在SL3261pMalE免疫后,八种MalE肽中的一种T细胞反应性消失,但这种现象可能是由于T细胞启动水平较低,因为通过进一步免疫可以克服这一现象。施用SL3261*pMalE最显著的效果是激活并刺激了新的MalE肽特异性T细胞反应,而这些反应在用佐剂施用纯化抗原后处于沉默状态。用MalE特异性T细胞杂交瘤进行的抗原呈递试验表明,这种细胞内减毒细菌感染抗原呈递细胞不会影响主要组织相容性复合体(MHC)II类分子对不同MalE肽的加工和呈递,因此不能解释免疫显性调节。因此,T细胞对微生物反应的免疫显性不仅受可用T细胞库的频率或导致MHC呈递的抗原呈递细胞中的加工步骤控制,还受可能与感染过程和细菌产物相关的其他参数控制。我们的结果表明,在被微生物感染后,针对其抗原诱导的T细胞反应的特异性可能比纯化抗原更有效,并且不能完全被佐剂联合使用的纯化抗原所模拟。